biosimilar rituximab 投稿者：Sonya 投稿日：2025/12/24(Wed) 18:29 No.3015629 
|
- 返信フォーム
biosimilar rituximab - Sonya 2025/12/24(Wed) 18:29 No.3015629
biosimilar rituximab 投稿者：Sonya 投稿日：2025/12/24(Wed) 18:29 No.3015629
37.Genovese MC, Cohen S, Moreland L, et al. 20000223 Examine Group Mixture therapy with etanercept and anakinra within the remedy of patients with rheumatoid arthritis who've been handled unsuccessfully with methotrexate. 38.Weinblatt M, Combe B, Covucci A, Aranda R, Becker JC, Keystone E. Security of the selective costimulation modulator abatacept in rheumatoid arthritis patients receiving background biologic and nonbiologic illness-modifying antirheumatic medication: A one-12 months randomized, placebo-managed examine. 39.Assmann G, Pfreundschuh M, Voswinkel J. Rituximab in patients with rheumatoid arthritis and vasculitis-related cutaneous ulcers. 40.Chandra PA, Margulis Y, Schiff C. Rituximab is beneficial within the remedy of Felty’s syndrome. 41.Iaccheri B, Androudi S, Bocci EB, Gerli R, Cagini C, Fiore T. Rituximab treatment for persistent scleritis related to rheumatoid arthritis. 42.Bredemeier M, de Oliveira FK, Rocha CM. Low- versus excessive-dose rituximab for rheumatoid arthritis: A scientific assessment and meta-evaluation. 43.Baker JF, Ostergaard M, Emery P, et al. Early MRI measures independently predict 1-12 months and 2-yr radiographic development in rheumatoid arthritis: secondary evaluation from a big clinical trial.
Also visit my website ... biosimilar rituximab (https://www.facebook.com/rituximabprecio/)
- 返信フォーム